𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study

✍ Scribed by Nicola Pavese; Maria Rivero-Bosch; Stephanie J. Lewis; Alan L. Whone; David J. Brooks

Book ID
119331917
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
261 KB
Volume
56
Category
Article
ISSN
1053-8119

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rate of progression in Parkinson's disea
Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study
✍ Elina Nurmi; Hanna M. Ruottinen; JΓΆrgen Bergman; Merja Haaparanta; Olof Solin; P πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

## Abstract The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6‐[^18^F]fluoro‐L‐dopa (FDOPA) positron emission tomography (PET). We investigated 21 patients with PD and eight healthy controls. Ten of the patients were de novo at the time of the first

Nigrostriatal dysfunction in homozygous
Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18F-dopa PET progression study
✍ Nicola Pavese; Naheed L. Khan; Christoph Scherfler; Lisa Cohen; David J. Brooks; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

## Abstract Little is known about the rate of progression of striatal dysfunction in subjects with __parkin__‐linked parkinsonism. Being a heterozygous __parkin__ gene carrier may confer susceptibility to Parkinson's disease (PD). In a previous ^18^F‐dopa PET study, we reported that 69% of carriers